Comparison between Clinitech Laboratory IPO and Esprit Stones IPO.
Clinitech Laboratory IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Esprit Stones IPO is a SME Bookbuilding proposed to list at NSE SME.
| Clinitech Laboratory IPO | Esprit Stones IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Inventure Merchant Banker Services Pvt.Ltd. | Srujan Alpha Capital Advisors LLP |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Svcm Securities Pvt.Ltd. | Choice Equity Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Clinitech Laboratory IPO is up to ₹5.48 Cr whereas the issue size of the Esprit Stones IPO is up to ₹47.82 Cr. The final issue price of Clinitech Laboratory IPO is ₹96.00 per share and of Esprit Stones IPO is ₹87.00 per share.
| Clinitech Laboratory IPO | Esprit Stones IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹82.00 per share | |
| Issue Price (Upper) | ₹87.00 per share | |
| Issue Price (Final) | ₹96.00 per share | ₹87.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹5.00 per share | |
| Market Lot Size | 1200 shares | 1600 shares |
| Fresh Issue Size | 5,71,200 shares | 55,04,000 shares |
| Fresh Issue Size (Amount) | up to ₹5.48 Cr | up to ₹47.82 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 5,71,200 shares | 55,04,000 shares |
| Issue Size Total (Amount) | up to ₹5.48 Cr | up to ₹47.82 Cr |
Clinitech Laboratory IPO opens on Jul 25, 2024, while Esprit Stones IPO opens on Jul 26, 2024. The closing date of Clinitech Laboratory IPO and Esprit Stones IPO is Jul 29, 2024, and Jul 30, 2024, respectively.
| Clinitech Laboratory IPO | Esprit Stones IPO | |
|---|---|---|
| Anchor Bid Date | Jul 25, 2024 | |
| Issue Open | Jul 25, 2024 | Jul 26, 2024 |
| Issue Close | Jul 29, 2024 | Jul 30, 2024 |
| Basis Of Allotment (Tentative) | Jul 30, 2024 | Jul 31, 2024 |
| Initiation of Refunds (Tentative) | Jul 31, 2024 | Aug 01, 2024 |
| Credit of Share (Tentative) | Jul 31, 2024 | Aug 01, 2024 |
| Listing date (Tentative) | Aug 01, 2024 | Aug 02, 2024 |
| Anchor Lockin End date 1 | Aug 30, 2024 | |
| Anchor Lockin End date 2 | Oct 29, 2024 |
Clinitech Laboratory IPO P/E ratio is 43.45, as compared to Esprit Stones IPO P/E ratio of 13.62.
| Clinitech Laboratory IPO | Esprit Stones IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Clinitech Laboratory Limited Financial Information (Restated)Clinitech Laboratory Limited's revenue increased by 1.19% and profit after tax (PAT) dropped by -39.46% between the financial year ending with March 31, 2024 and March 31, 2023.
| Esprit Stones Limited Financial Information (Restated)Esprit Stones Limited's revenue increased by 56.07% and profit after tax (PAT) rose by 190.04% between the financial year ending with March 31, 2024 and March 31, 2023.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.63 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.56 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 43.45 | 13.62 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹21.91 Cr. | ₹190.92 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 12.39% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.24 | 1.72 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.21 | ₹6.39 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10.46% | 15.09% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Clinitech Laboratory IPO Retail Individual Investors (RII) are offered 2,85,600 shares while in Esprit Stones IPO retail investors are offered 2,85,600 shares. Qualified Institutional Buyers (QIB) are offered in Clinitech Laboratory IPO and 10,75,200 shares in Esprit Stones IPO.
| Clinitech Laboratory IPO | Esprit Stones IPO | |
|---|---|---|
| Anchor Investor Reserveration | 16,12,800 shares | |
| Market Maker Reserveration | 31,200 shares | 2,91,200 shares |
| QIB | 10,75,200 shares | |
| NII | 2,85,600 shares | 8,06,400 shares |
| RII | 2,85,600 shares | 18,81,600 shares |
| Employee | 1,28,000 shares | |
| Others | ||
| Total | 5,71,200 shares | 55,04,000 shares |
Clinitech Laboratory IPO subscribed 38.96x in total, whereas Esprit Stones IPO subscribed 185.82x.
| Clinitech Laboratory IPO | Esprit Stones IPO | |
|---|---|---|
| QIB (times) | 117.63x | |
| NII (times) | 23.28x | 399.58x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 49.61x | 145.75x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 38.96x | 185.82x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
